These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1688435)

  • 1. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100.
    Pease RJ; Milne RW; Jessup WK; Law A; Provost P; Fruchart JC; Dean RT; Marcel YL; Scott J
    J Biol Chem; 1990 Jan; 265(1):553-68. PubMed ID: 1688435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation.
    Chen PF; Marcel YL; Yang CY; Gotto AM; Milne RW; Sparrow JT; Chan L
    Eur J Biochem; 1988 Jul; 175(1):111-8. PubMed ID: 2456922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47.
    Young SG; Koduri RK; Austin RK; Bonnet DJ; Smith RS; Curtiss LK
    J Lipid Res; 1994 Mar; 35(3):399-407. PubMed ID: 7516960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B.
    Milne R; Théolis R; Maurice R; Pease RJ; Weech PK; Rassart E; Fruchart JC; Scott J; Marcel YL
    J Biol Chem; 1989 Nov; 264(33):19754-60. PubMed ID: 2479639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of human apolipoprotein B antigenic determinants.
    Marcel YL; Innerarity TL; Spilman C; Mahley RW; Protter AA; Milne RW
    Arteriosclerosis; 1987; 7(2):166-75. PubMed ID: 2437897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional specificities of monoclonal anti-human apolipoprotein B antibodies.
    Krul ES; Kleinman Y; Kinoshita M; Pfleger B; Oida K; Law A; Scott J; Pease R; Schonfeld G
    J Lipid Res; 1988 Jul; 29(7):937-47. PubMed ID: 2457642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to human low density lipoprotein identify distinct areas on apolipoprotein B-100 relevant to the low density lipoprotein-receptor interaction.
    Fantappiè S; Corsini A; Sidoli A; Uboldi P; Granata A; Zanelli T; Rossi P; Marcovina S; Fumagalli R; Catapano AL
    J Lipid Res; 1992 Aug; 33(8):1111-21. PubMed ID: 1279088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat monoclonal antibodies to rabbit and human serum low-density lipoprotein.
    Gherardi E; Hutchings A; Galfre G; Bowyer DE
    Biochem J; 1988 May; 252(1):237-45. PubMed ID: 2458711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat monoclonal antibodies to human apolipoprotein B: advantages and applications.
    Fievet C; Durieux C; Milne R; Delaunay T; Agnani G; Bazin H; Marcel Y; Fruchart JC
    J Lipid Res; 1989 Jul; 30(7):1015-24. PubMed ID: 2477482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody 5A binds apolipoprotein B-48 and inhibits the low density lipoprotein-receptor interaction.
    Corsini A; Fantappiè S; Marcovina S; Granata A; Fumagalli R; Catapano AL
    Biochem Biophys Res Commun; 1989 Aug; 162(3):908-15. PubMed ID: 2475112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
    J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein.
    Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M
    Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100.
    Wei CF; Chen SH; Yang CY; Marcel YL; Milne RW; Li WH; Sparrow JT; Gotto AM; Chan L
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7265-9. PubMed ID: 2932736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies distinguish between lipid-dependent and reversible conformational states of human apolipoprotein B.
    Milne RW; Blanchette L; Théolis R; Weech PK; Marcel YL
    Mol Immunol; 1987 May; 24(5):435-47. PubMed ID: 2443835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins.
    Viens L; Lagrost L
    J Lipid Res; 1997 Jun; 38(6):1129-38. PubMed ID: 9215541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function.
    Marcel YL; Hogue M; Weech PK; Davignon J; Milne RW
    Arteriosclerosis; 1988; 8(6):832-44. PubMed ID: 2461695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of antigenic determinants on human solubilized apolipoprotein B. Conformational requirements for lipids.
    Marcel YL; Hogue M; Weech PK; Milne RW
    J Biol Chem; 1984 Jun; 259(11):6952-7. PubMed ID: 6202688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.
    Borén J; Ekström U; Agren B; Nilsson-Ehle P; Innerarity TL
    J Biol Chem; 2001 Mar; 276(12):9214-8. PubMed ID: 11115503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.